Effect of reteplase on hemostasis variables: analysis of fibrin specifity, relation to bleeding complications and coronary patency

This publication has 15 references indexed in Scilit:

• Randomized Comparison of Coronary Thrombolysis Achieved With Double-Bolus Reteplase (Recombinant Plasminogen Activator) and Front-Loaded, Accelerated Alteplase (Recombinant Tissue Plasminogen Activator) in Patients With Acute Myocardial Infarction
  Circulation, 1996
• Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence
  The Lancet, 1995
• More Rapid, Complete, and Stable Coronary Thrombolysis With Bolus Administration of Reteplase Compared With Alteplase Infusion in Acute Myocardial Infarction
  Circulation, 1995
• Dose finding with a novel recombinant plasminogen activator (BM 06,022) in patients with acute myocardial infarction: Results of the German recombinant plasminogen activator study
  Journal of the American College of Cardiology, 1994
• Thrombolytic Therapy for Acute Myocardial Infarction
  Drugs, 1992
• Pharmacokinetics and fibrin specificity of alteplase during accelerated infusions in acute myocardial infarction
  Journal of the American College of Cardiology, 1992
• Single-bolus injection of recombinant tissue-type plasminogen activator in acute myocardial infarction
  The American Journal of Cardiology, 1989
• Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase
  Journal of the American College of Cardiology, 1988
• Relation of effectiveness of intracoronary thrombolysis in acute myocardial infarction to systemic thrombolytic state
  The American Journal of Cardiology, 1985
• Relationship of the lytic state to successful reperfusion with standard- and low-dose intracoronary streptokinase.
  Circulation, 1985